Viewing Study NCT00003293


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-27 @ 2:35 AM
Study NCT ID: NCT00003293
Status: COMPLETED
Last Update Posted: 2012-09-11
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module